Research.Patient.info
Obstructive Hypertrophic Cardiomyopathy. research hub
2 indexed studies · 1 currently recruiting
- authorisedTherapeutic use (Phase IV)
A study on stopping versus continuing beta-blockers in patients with hypertrophic cardiomyopathy treated with mavacamten
This study looks at adults with obstructive hypertrophic cardiomyopathy who take a medicine called mavacamten. Researchers want to find out if it is safe and helpful to stop taking beta-blocker tablets once mavacamten is working, or whether it is better to stay on both medicines.
Belgium - recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
This study looks at how people with a heart condition called obstructive hypertrophic cardiomyopathy (HCM) are treated in real life. It compares a new medicine called mavacamten with other treatments, focusing on how patients feel and how their condition progresses over time.
United States · Austria · Czechia